263 related articles for article (PubMed ID: 25825450)
1. Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire.
Scheepers C; Shrestha RK; Lambson BE; Jackson KJ; Wright IA; Naicker D; Goosen M; Berrie L; Ismail A; Garrett N; Abdool Karim Q; Abdool Karim SS; Moore PL; Travers SA; Morris L
J Immunol; 2015 May; 194(9):4371-8. PubMed ID: 25825450
[TBL] [Abstract][Full Text] [Related]
2. Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations.
Hicar MD; Chen X; Kalams SA; Sojar H; Landucci G; Forthal DN; Spearman P; Crowe JE
Mol Immunol; 2016 Feb; 70():94-103. PubMed ID: 26748387
[TBL] [Abstract][Full Text] [Related]
3. On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?
Parsons MS; Muller S; Kohler H; Grant MD; Bernard NF
Hum Vaccin Immunother; 2013 Jul; 9(7):1532-8. PubMed ID: 23571168
[TBL] [Abstract][Full Text] [Related]
4. Inferred Allelic Variants of Immunoglobulin Receptor Genes: A System for Their Evaluation, Documentation, and Naming.
Ohlin M; Scheepers C; Corcoran M; Lees WD; Busse CE; Bagnara D; Thörnqvist L; Bürckert JP; Jackson KJL; Ralph D; Schramm CA; Marthandan N; Breden F; Scott J; Matsen Iv FA; Greiff V; Yaari G; Kleinstein SH; Christley S; Sherkow JS; Kossida S; Lefranc MP; van Zelm MC; Watson CT; Collins AM
Front Immunol; 2019; 10():435. PubMed ID: 30936866
[TBL] [Abstract][Full Text] [Related]
5. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
McGuire AT; Glenn JA; Lippy A; Stamatatos L
J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
[TBL] [Abstract][Full Text] [Related]
6. The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development.
Zhang Y; Yuan T; Li J; Zhang Y; Xu J; Shao Y; Chen Z; Zhang MY
AIDS; 2013 Oct; 27(16):2529-39. PubMed ID: 24100711
[TBL] [Abstract][Full Text] [Related]
7. A single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to HIV-1 envelope glycoproteins.
Yuan T; Li J; Zhang MY
MAbs; 2011; 3(4):402-7. PubMed ID: 21540646
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease.
Breden F; Lepik C; Longo NS; Montero M; Lipsky PE; Scott JK
PLoS One; 2011 Mar; 6(3):e16857. PubMed ID: 21479208
[TBL] [Abstract][Full Text] [Related]
9. Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies.
Pujanauski LM; Janoff EN; McCarter MD; Pelanda R; Torres RM
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1422-7. PubMed ID: 23288906
[TBL] [Abstract][Full Text] [Related]
10. Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject.
Li L; Wang XH; Banerjee S; Volsky B; Williams C; Virland D; Nadas A; Seaman MS; Chen X; Spearman P; Zolla-Pazner S; Gorny MK
PLoS One; 2012; 7(6):e39534. PubMed ID: 22761815
[TBL] [Abstract][Full Text] [Related]
11. Human Anti-HIV-1 gp120 Monoclonal Antibodies with Neutralizing Activity Cloned from Humanized Mice Infected with HIV-1.
Gawron MA; Duval M; Carbone C; Jaiswal S; Wallace A; Martin JC; Dauphin A; Brehm MA; Greiner DL; Shultz LD; Luban J; Cavacini LA
J Immunol; 2019 Feb; 202(3):799-804. PubMed ID: 30593536
[TBL] [Abstract][Full Text] [Related]
12. Critical steps for computational inference of the 3'-end of novel alleles of immunoglobulin heavy chain variable genes - illustrated by an allele of IGHV3-7.
Thörnqvist L; Ohlin M
Mol Immunol; 2018 Nov; 103():1-6. PubMed ID: 30172112
[TBL] [Abstract][Full Text] [Related]
13. Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.
Andrabi R; Su CY; Liang CH; Shivatare SS; Briney B; Voss JE; Nawazi SK; Wu CY; Wong CH; Burton DR
Immunity; 2017 Sep; 47(3):524-537.e3. PubMed ID: 28916265
[TBL] [Abstract][Full Text] [Related]
14. Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline.
Georgiev IS; Rudicell RS; Saunders KO; Shi W; Kirys T; McKee K; O'Dell S; Chuang GY; Yang ZY; Ofek G; Connors M; Mascola JR; Nabel GJ; Kwong PD
J Immunol; 2014 Feb; 192(3):1100-1106. PubMed ID: 24391217
[TBL] [Abstract][Full Text] [Related]
15. Human antibody variable region gene usage in HIV-1 infection.
Wisnewski A; Cavacini L; Posner M
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):31-8. PubMed ID: 8528730
[TBL] [Abstract][Full Text] [Related]
16. Shaping of human germline IgH repertoires revealed by deep sequencing.
Larimore K; McCormick MW; Robins HS; Greenberg PD
J Immunol; 2012 Sep; 189(6):3221-30. PubMed ID: 22865917
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the horse V(H) repertoire and comparison with the human IGHV germline genes, and sheep, cattle and pig V(H) sequences.
Almagro JC; Martinez L; Smith SL; Alagon A; Estevez J; Paniagua J
Mol Immunol; 2006 Apr; 43(11):1836-45. PubMed ID: 16337682
[TBL] [Abstract][Full Text] [Related]
18. The human immunoglobulin heavy variable genes.
Pallarès N; Lefebvre S; Contet V; Matsuda F; Lefranc MP
Exp Clin Immunogenet; 1999; 16(1):36-60. PubMed ID: 10087405
[TBL] [Abstract][Full Text] [Related]
19. Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization.
Willis JR; Finn JA; Briney B; Sapparapu G; Singh V; King H; LaBranche CC; Montefiori DC; Meiler J; Crowe JE
Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4446-51. PubMed ID: 27044078
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization.
Navis M; Tran K; Bale S; Phad GE; Guenaga J; Wilson R; Soldemo M; McKee K; Sundling C; Mascola J; Li Y; Wyatt RT; Karlsson Hedestam GB
PLoS Pathog; 2014 Aug; 10(8):e1004337. PubMed ID: 25166308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
